Literature DB >> 3600615

Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.

S K Fisher, R M Snider.   

Abstract

The potency with which carbamoylcholine enhances phosphoinositide (PPI) hydrolysis in different brain regions (neostriatum, cerebral cortex, and hippocampus) and in two neuroblastomas (the murine N1E-115 and human SK-N-SH) differs by 10- to 20-fold. To determine whether the presence of a muscarinic receptor (mAChR) reserve might account for these differences, we have examined the effect of propylbenzilylcholine mustard (PrBCM) on mAChR number and on agonist-stimulated PPI hydrolysis. In the cerebral cortex, in hippocampus, and in N1E-115 cells, PrBCM treatment resulted in a loss of the PPI response, as measured by the release of [3H]inositol phosphates, that was equal to or greater than the reduction in receptor number, as determined by the loss of either [3H]quinuclidinylbenzilate- or [3H]N-methylscopolamine-binding sites. From dose response curves for carbamoylcholine, it was determined that alkylation of mAChRs resulted in a reduction in the maximum release of inositol phosphates but had no effect on agonist potency. The KA values for carbamoylcholine obtained following receptor inactivation were similar to those for the EC50 (120-316 microM). In contrast, in both the neostriatum and SK-N-SH cells, PrBCM treatment resulted in a greater loss of mAChR number than of stimulated inositol phosphate release, and dose response curves for carbamoylcholine were shifted to higher agonist concentrations. The KA values (34-65 microM) were 2- to 9-fold higher than the comparable EC50 values. Moreover, in both tissues the PPI response elicited by partial agonists was more susceptible to receptor alkylation than that elicited by carbamoylcholine. The two groups of tissues also differ in their sensitivity to pirenzepine, which is a markedly weaker antagonist of stimulated PPI hydrolysis in SK-N-SH cells and neostriatum (Ki 160-250 nM), than in the cerebral cortex, hippocampus, and N1E-115 cells (Ki 10-20 nM). These results suggest: 1) that a population of "spare" receptors exists for mAChR-mediated inositol lipid hydrolysis in some neuronal tissues, 2) that both M1 and M2 mAChRs may be coupled to PPI turnover, and 3) that M2 mAChRs appear to be more efficiently coupled to phosphoinositide hydrolysis than their M1 counterparts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3600615

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  18 in total

1.  Neurotransmitter-mediated inhibition of post-mortem human brain adenylyl cyclase.

Authors:  A Garlind; C J Fowler; I Alafuzoff; B Winblad; R F Cowburn
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models.

Authors:  Gregory J Digby; Meredith J Noetzel; Michael Bubser; Thomas J Utley; Adam G Walker; Nellie E Byun; Evan P Lebois; Zixiu Xiang; Douglas J Sheffler; Hyekyung P Cho; Albert A Davis; Natali E Nemirovsky; Sarah E Mennenga; Bryan W Camp; Heather A Bimonte-Nelson; Jacob Bode; Kimberly Italiano; Ryan Morrison; J Scott Daniels; Colleen M Niswender; M Foster Olive; Craig W Lindsley; Carrie K Jones; P Jeffrey Conn
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

Review 3.  Agonist efficacy and receptor desensitization: from partial truths to a fuller picture.

Authors:  Steven J Charlton
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

4.  Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells.

Authors:  M J Marino; S T Rouse; A I Levey; L T Potter; P J Conn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Rho family GTPases and neuronal growth cone remodelling: relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid.

Authors:  R Kozma; S Sarner; S Ahmed; L Lim
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  A rapid attenuation of muscarinic agonist stimulated phosphoinositide hydrolysis precedes receptor sequestration in human SH-SY-5Y neuroblastoma cells.

Authors:  S K Fisher; D M Slowiejko; E L McEwen
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

7.  Down-regulation of brain muscarinic cholinergic receptor promoted by diacylglycerols and phorbol ester.

Authors:  M F Pediconi; F J Barrantes
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

8.  Muscarinic receptors coupled to phosphoinositide hydrolysis and elevated cytosolic calcium in a human neuroblastoma cell line SK-N-SH.

Authors:  J G Baird; D G Lambert; J McBain; S R Nahorski
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

9.  Changes in extracellular calcium within the physiological range influence receptor-mediated inositol phosphate responses in brain and tracheal smooth muscle slices.

Authors:  J G Baird; E R Chilvers; E D Kennedy; S R Nahorski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

10.  The neuropeptide bradykinin stimulates phosphoinositide turnover in HSDM1C1 cells: B2-antagonist-sensitive responses and receptor binding studies.

Authors:  N A Sharif; R L Whiting
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.